ARCHIVES

JRB Wins $3.6 Million Support contract

This article is from The Cancer Letter archive.

Vol. 01 No. 43 | November 29, 1974

Download PDF Visit The Full Archive

Related Articles

Tivozanib Trumps Sorafenib In 1st-Line Renal Cancer Study

May 25, 2012

Gio Gori And The “Tolerable” Smoking Flap; Controversy When He Needs It Least

August 18, 1978

Cooperative Groups Pursue Contracts With Insurers, NCI Warns of Competition

June 14, 1996

NCI Gets Out of the News Business

January 25, 2013

Includes January Business & Regulatory Report (8-page issue).

January 31, 2003

The Cancer Letter takes summer publication break, back Sept. 12.

August 8, 2003